OWINGS MILLS, Md., May 21 /PRNewswire/ -- Bradley T. MacDonald, Chairman of the Board of HealthRite, Inc. (Nasdaq: HLRT) announced today the Company's financial results for its quarter ending March 31, 1999. During the quarter, the Company had a loss from operations of $648,000, compared to a loss of $629,000 for the quarter ending March 31, 1998. The Company's net loss was $769,000, or $.14 per share, fully diluted, compared to 1998's net loss of $710,000, or $.16 per share, fully diluted. Revenues for the Company were $2,892,000 in 1999, compared to $2,941,000 in 1998. Additionally, Bradley T. MacDonald, the Company's Chairman and Chief Executive Officer, announced that revenues from their weight management division, Jason Pharmaceuticals, grew 11% over the previous year. Montana Naturals' largest contract customer determined that they had excess inventory. This caused a temporary cancellation of new orders. These cancellations, as well as the major pharmaceutical companies entering the herbal supplement business, depressed sales and earnings, and may continue to affect Montana Naturals revenues in the near future. Mr. MacDonald stated that, "While we are unhappy with the loss for the quarter, we are satisfied with the progress of our new product, Medifast Take Shape(TM)." Modeled after the physician directed Medifast(R), the Medifast Take Shape(TM) product is designed for use without medical supervision. Medifast Take Shape(TM) has moved into grocery chains such as Albertson's, Ralph's, Mars, Stop 'N Shop, Giant Foods and ShopRite. Medifast.net, E commerce strategy as an umbrella to its physician network, is already generating new customers for Medifast(R). The Company is negotiating with major pharmaceutical and neutraceutical companies seeking a strategic partnership. This release contains forward-looking statements which may involve known and unknown risks, uncertainties and other factors that may cause HealthRite's actual results and performance in future periods to be materially different from any future results or performance suggested by these statements. HealthRite cautions investors not to place undue reliance on forward-looking statements, which speak only to management's expectation on this date.  